108 related articles for article (PubMed ID: 20390384)
1. Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma.
Middendorp M; Maute L; Sauter B; Vogl TJ; Grünwald F
Ann Nucl Med; 2010 Jul; 24(6):441-6. PubMed ID: 20390384
[TBL] [Abstract][Full Text] [Related]
2. The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Kakizoe M; Yao M; Tateishi U; Minamimoto R; Ueno D; Namura K; Makiyama K; Hayashi N; Sano F; Kishida T; Kobayashi K; Noguchi S; Ikeda I; Ohgo Y; Taguri M; Morita S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2014 Jun; 14():390. PubMed ID: 24885730
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of response to multikinase inhibitor in metastatic renal cell carcinoma by FDG PET/contrast-enhanced CT.
Minamimoto R; Nakaigawa N; Tateishi U; Suzuki A; Shizukuishi K; Kishida T; Miura T; Makiyama K; Yao M; Kubota Y; Inoue T
Clin Nucl Med; 2010 Dec; 35(12):918-23. PubMed ID: 21206220
[TBL] [Abstract][Full Text] [Related]
4. Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.
Revheim ME; Winge-Main AK; Hagen G; Fjeld JG; Fosså SD; Lilleby W
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):339-43. PubMed ID: 21134733
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT.
Hartenbach M; Weber S; Albert NL; Hartenbach S; Hirtl A; Zacherl MJ; Paprottka PM; Tiling R; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1661-6. PubMed ID: 26405170
[TBL] [Abstract][Full Text] [Related]
6. The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.
Nakaigawa N; Kondo K; Ueno D; Namura K; Makiyama K; Kobayashi K; Shioi K; Ikeda I; Kishida T; Kaneta T; Minamimoto R; Tateishi U; Inoue T; Yao M
BMC Cancer; 2017 Jan; 17(1):39. PubMed ID: 28068944
[TBL] [Abstract][Full Text] [Related]
7. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Aurangabadkar H; Ali Z
Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
[TBL] [Abstract][Full Text] [Related]
8. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT in detection of adrenal metastasis in patients with renal cell carcinoma.
Kumar R; Shamim SA; Shandal V; Sharma P; Gadodia A; Malhotra A
Clin Nucl Med; 2011 Jul; 36(7):513-7. PubMed ID: 21637050
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study.
Vercellino L; Bousquet G; Baillet G; Barré E; Mathieu O; Just PA; Desgrandchamps F; Misset JL; Hindié E; Moretti JL
Cancer Biother Radiopharm; 2009 Feb; 24(1):137-44. PubMed ID: 19243256
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.
Divgi CR; Uzzo RG; Gatsonis C; Bartz R; Treutner S; Yu JQ; Chen D; Carrasquillo JA; Larson S; Bevan P; Russo P
J Clin Oncol; 2013 Jan; 31(2):187-94. PubMed ID: 23213092
[TBL] [Abstract][Full Text] [Related]
12. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Fuccio C; Ceci F; Castellucci P; Spinapolice EG; Palumbo R; D'Ambrosio D; Bernardo A; Brunocilla E; Schiavina R; Maffione AM; Chondrogiannis S; Grassetto G; Colletti PM; Rubello D; Fanti S; Trifirò G
Clin Nucl Med; 2014 Jun; 39(6):e320-4. PubMed ID: 24566409
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy.
Yoon HJ; Paeng JC; Kwak C; Park YH; Kim TM; Lee SH; Chung JK; Edmund Kim E; Lee DS
Ann Nucl Med; 2013 Oct; 27(8):748-55. PubMed ID: 23818007
[TBL] [Abstract][Full Text] [Related]
14. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
15. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
16. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
17. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
[TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
19. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
[TBL] [Abstract][Full Text] [Related]
20. [PET/CT with (18F)FDG in the initial staging of a pelvic kidney neoplasm. A case report].
Pifarré Montaner P; Simó Perdigó M; Plaza López P; Marco V; Alvarez Castells A; Martínez-Miralles E
Rev Esp Med Nucl; 2009; 28(4):200-3. PubMed ID: 19922833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
